{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/12093"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/12093","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"The role of UCH-L1 in autophagy and mitochondrial turnover","abstract":"Parkinson’s disease (PD) is a neurodegenerative disorder caused by both environmental and genetic factors. Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) genetic mutations have been implicated in PD pathogenesis, potentially due to changes in autophagy. Recent reports suggest that autophagy is not affected when mitochondrial UCH-L1 is inhibited, reflected by the autophagy marker, microtubule-associated protein 1 light chain 3, or LC3. However, these experiments discount the fact that autophagy is not static, but a dynamic cycle that must be measured appropriately (Cartier et al, 2012). Using this as the driving force of my study, I suppressed autophagy with the lysosomal inhibitor bafilomycin in addition to inhibiting UCH-L1. Using an insulinoma cell line, a neuroblastoma cell line, and primary neurons, I illustrate that LC3-II levels rise due to an increase in autophagic flux and not because of a decrease in autophagosome clearance. These findings also shed light on how UCH-L1 can be studied as a future target for PD prevention and treatment with respect to autophagy.","abstract_html":"Parkinson’s disease (PD) is a neurodegenerative disorder caused by both environmental and genetic factors. Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) genetic mutations have been implicated in PD pathogenesis, potentially due to changes in autophagy. Recent reports suggest that autophagy is not affected when mitochondrial UCH-L1 is inhibited, reflected by the autophagy marker, microtubule-associated protein 1 light chain 3, or LC3. However, these experiments discount the fact that autophagy is not static, but a dynamic cycle that must be measured appropriately (Cartier et al, 2012). Using this as the driving force of my study, I suppressed autophagy with the lysosomal inhibitor bafilomycin in addition to inhibiting UCH-L1. Using an insulinoma cell line, a neuroblastoma cell line, and primary neurons, I illustrate that LC3-II levels rise due to an increase in autophagic flux and not because of a decrease in autophagosome clearance. These findings also shed light on how UCH-L1 can be studied as a future target for PD prevention and treatment with respect to autophagy.","abstract_has_math":false,"creators":["Eaves, Ashley Marie"],"institution":"Boston University","degree_name":"Master of Arts","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013","date_published":"2013","updated_at":"2026-11-18T20:42:02Z","subjects":[],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/12093","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/12093","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F12093","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Eaves, Ashley Marie"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2015-08-04T15:36:21Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2015-08-04T15:36:21Z"]},{"key":"dc:date.issued","label":"Date","values":["2013"]},{"key":"dc:date.submitted","label":"Dc Date Submitted","values":["2013"]},{"key":"dc:publisher","label":"Institution","values":["Boston University"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Arts"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/12093"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (M.A.)--Boston University"]},{"key":"dc:description.abstract","label":"Abstract","values":["Parkinson’s disease (PD) is a neurodegenerative disorder caused by both environmental and genetic factors. Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) genetic mutations have been implicated in PD pathogenesis, potentially due to changes in autophagy. Recent reports suggest that autophagy is not affected when mitochondrial UCH-L1 is inhibited, reflected by the autophagy marker, microtubule-associated protein 1 light chain 3, or LC3. However, these experiments discount the fact that autophagy is not static, but a dynamic cycle that must be measured appropriately (Cartier et al, 2012). Using this as the driving force of my study, I suppressed autophagy with the lysosomal inhibitor bafilomycin in addition to inhibiting UCH-L1. Using an insulinoma cell line, a neuroblastoma cell line, and primary neurons, I illustrate that LC3-II levels rise due to an increase in autophagic flux and not because of a decrease in autophagosome clearance. These findings also shed light on how UCH-L1 can be studied as a future target for PD prevention and treatment with respect to autophagy."]},{"key":"dc:title","label":"Title","values":["The role of UCH-L1 in autophagy and mitochondrial turnover"]}]}],"canonical_facts":{"dc:creator":["Eaves, Ashley Marie"],"dc:date.accessioned":["2015-08-04T15:36:21Z"],"dc:date.available":["2015-08-04T15:36:21Z"],"dc:date.issued":["2013"],"dc:date.submitted":["2013"],"dc:description":["Thesis (M.A.)--Boston University"],"dc:description.abstract":["Parkinson’s disease (PD) is a neurodegenerative disorder caused by both environmental and genetic factors. Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) genetic mutations have been implicated in PD pathogenesis, potentially due to changes in autophagy. Recent reports suggest that autophagy is not affected when mitochondrial UCH-L1 is inhibited, reflected by the autophagy marker, microtubule-associated protein 1 light chain 3, or LC3. However, these experiments discount the fact that autophagy is not static, but a dynamic cycle that must be measured appropriately (Cartier et al, 2012). Using this as the driving force of my study, I suppressed autophagy with the lysosomal inhibitor bafilomycin in addition to inhibiting UCH-L1. Using an insulinoma cell line, a neuroblastoma cell line, and primary neurons, I illustrate that LC3-II levels rise due to an increase in autophagic flux and not because of a decrease in autophagosome clearance. These findings also shed light on how UCH-L1 can be studied as a future target for PD prevention and treatment with respect to autophagy."],"dc:identifier.uri":["https://hdl.handle.net/2144/12093"],"dc:language.iso":["en_US"],"dc:publisher":["Boston University"],"dc:title":["The role of UCH-L1 in autophagy and mitochondrial turnover"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Arts"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:42:02Z"}